Nuveen’s HOOKIPA Pharma HOOK Stock Holding History

Nuveen’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,097	Closed	-$212K	–	3359
2022 Q1	$212K	Sell	13,097 -3,527	-21%	-$63.2K	﹤0.01%	3181
2021 Q4	$427K	Sell	16,624 -508	-3%	-$20.4K	﹤0.01%	3108
2021 Q3	$1.16M	Sell	17,132 -120	-0.7%	-$8.7K	﹤0.01%	2939
2021 Q2	$1.58M	Buy	17,252 +10,259	+147%	+$1.37M	﹤0.01%	2814
2021 Q1	$941K	Buy	6,993 +1,837	+36%	+$222K	﹤0.01%	2903
2020 Q4	$572K	Sell	5,156 -796	-13%	-$86K	﹤0.01%	3011
2020 Q3	$563K	Sell	5,952 -690	-10%	-$70.4K	﹤0.01%	2913
2020 Q2	$772K	Buy	6,642 +2,692	+68%	+$262K	﹤0.01%	2729
2020 Q1	$326K	Buy	3,950 +2,851	+259%	+$312K	﹤0.01%	2911
2019 Q4	$134K	Hold	1,099	–	–	﹤0.01%	3108
2019 Q3	$82K	Buy	+1,099	New	+$81.1K	﹤0.01%	3178

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen's HOOK Position: Q2 2022 in Review

Nuveen sold out of HOOKIPA Pharma (HOOK) in Q2 2022, closing a stake of 13,097 shares — an estimated $212K sold.

Nuveen first reported a position in HOOK in Q3 2019 and held it in 11 quarters. The position peaked at $1.58M in Q2 2021. 58 funds tracked by Wall St. Rank hold HOOK as of Q2 2022.

Nuveen reported no remaining HOOKIPA Pharma position as of Q2 2022 after selling out during the quarter.
Nuveen sold 13,097 HOOKIPA Pharma shares in Q2 2022, an estimated $212K.
Nuveen first reported a position in HOOKIPA Pharma in Q3 2019 and held it in 11 quarters.
Nuveen's HOOKIPA Pharma position peaked at $1.58M in Q2 2021.
58 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.